Circulating Cell-Free SHOX2 DNA Methylation Is a Predictive, Prognostic, and Monitoring Biomarker in Adjuvant and Palliative Anti-PD-1-Treated Melanoma.
Clinical chemistry
View this publicationClinical chemistry
View this publicationJournal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
View this publicationFrontiers in immunology
View this publicationPigment cell & melanoma research
View this publicationEuropean journal of cancer (Oxford, England : 1990)
View this publicationOncoimmunology
View this publicationBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
View this publicationClinical epigenetics
View this publicationBiomarker research
View this publicationEuropean journal of cancer (Oxford, England : 1990)
View this publication